Prabha N. Ibrahim

7.8k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Prabha N. Ibrahim is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Prabha N. Ibrahim has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Prabha N. Ibrahim's work include Peroxisome Proliferator-Activated Receptors (3 papers), Phosphodiesterase function and regulation (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Prabha N. Ibrahim is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (3 papers), Phosphodiesterase function and regulation (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Prabha N. Ibrahim collaborates with scholars based in United States, Ecuador and Canada. Prabha N. Ibrahim's co-authors include Gideon Bollag, James Tsai, Chao Zhang, K. B. Nolop, Peter Hirth, Jiazhong Zhang, S. Gillette, Kam Y. J. Zhang, Dean R. Artis and Yoshihisa Suzuki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Biotechnology.

In The Last Decade

Prabha N. Ibrahim

16 papers receiving 1.4k citations

Hit Papers

Vemurafenib: the first drug approved for BRAF-mutant cancer 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vemurafenib: the first drug approved for BRAF-mutant cancer
    2012 594 citations Gideon Bollag, James Tsai et al. Nature Reviews Drug Discovery profile →

Peers

Prabha N. Ibrahim
Anne G. Graham United States
Jennifer J. Bouska United States
John R. Regan United States
Pier F. Cirillo United States
Kevin Kish United States
Elizabeth A. Lunney United States
Laurie Churchill United States
Hong Ding China
Steven E. Hall United States
John S. Tokarski United States
Anne G. Graham United States
Prabha N. Ibrahim
Citations per year, relative to Prabha N. Ibrahim Prabha N. Ibrahim (= 1×) peers Anne G. Graham

Countries citing papers authored by Prabha N. Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Prabha N. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabha N. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabha N. Ibrahim more than expected).

Fields of papers citing papers by Prabha N. Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prabha N. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabha N. Ibrahim. The network helps show where Prabha N. Ibrahim may publish in the future.

Co-authorship network of co-authors of Prabha N. Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Prabha N. Ibrahim. A scholar is included among the top collaborators of Prabha N. Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabha N. Ibrahim. Prabha N. Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bollag, Gideon, James Tsai, Jiazhong Zhang, et al.. (2012). Vemurafenib: the first drug approved for BRAF-mutant cancer. Nature Reviews Drug Discovery. 11(11). 873–886. 594 indexed citations breakdown →
2.
Perreault, Mylène, Sarah Will, Kimberly Harding, et al.. (2009). Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice. Diabetes Obesity and Metabolism. 12(3). 234–245. 10 indexed citations
3.
Bartberger, Michael D., Charles Bernard, Liang Huang, et al.. (2006). An efficient one-pot construction of substituted pyrimidinones. Tetrahedron. 62(50). 11714–11723. 3 indexed citations
4.
Card, G.L., B.P. England, Chao Zhang, et al.. (2005). A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design. Nature Biotechnology. 23(2). 201–207. 145 indexed citations
5.
Kumar, Abhinav, Valsan Mandiyan, Yoshihisa Suzuki, et al.. (2005). Crystal Structures of Proto-oncogene Kinase Pim1: A Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma. Journal of Molecular Biology. 348(1). 183–193. 136 indexed citations
6.
Zhang, Kam Y. J., Prabha N. Ibrahim, S. Gillette, & Gideon Bollag. (2005). Phosphodiesterase-4 as a potential drug target. Expert Opinion on Therapeutic Targets. 9(6). 1283–1305. 71 indexed citations
7.
Card, G.L., B.P. England, Yoshihisa Suzuki, et al.. (2004). Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases. Structure. 12(12). 2233–2247. 338 indexed citations
8.
Elzein, Elfatih, Kevin D. Shenk, Prabha N. Ibrahim, et al.. (2004). Novel inhibitors of fatty acid oxidation as potential metabolic modulators. Bioorganic & Medicinal Chemistry Letters. 14(4). 973–977. 6 indexed citations
9.
Elzein, Elfatih, Prabha N. Ibrahim, Venkata P. Palle, et al.. (2004). Structure–affinity relationships of 5′-aromatic ethers and 5′-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents. Bioorganic & Medicinal Chemistry Letters. 14(14). 3793–3797. 16 indexed citations
10.
Elzein, Elfatih, Prabha N. Ibrahim, Dmitry O. Koltun, et al.. (2004). CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 14(24). 6017–6021. 25 indexed citations
11.
Fraser, Heather, et al.. (2003). Conditional-dependent effects of CVT-4325, a novel fatty acid oxidation inhibitor, on palmitate utilization. Journal of the American College of Cardiology. 41(6). 253–253. 4 indexed citations
12.
13.
Burgess, Laurence E., Prabha N. Ibrahim, James P. Rizzi, et al.. (1999). Potent selective nonpeptidic inhibitors of human lung tryptase. Proceedings of the National Academy of Sciences. 96(15). 8348–8352. 54 indexed citations
14.
Gałęzowski, Włodzimierz, Prabha N. Ibrahim, & Edward S. Lewis. (1993). Methyl transfers. 15. CoIPc- as a nucleophile and leaving group. Journal of the American Chemical Society. 115(19). 8660–8668. 19 indexed citations
15.
McKinley, Allan J., Prabha N. Ibrahim, V. Balaji, & Josef Michl. (1992). Long-range spin density propagation in saturated hydrocarbons: 3-[n]staffyl radicals. Journal of the American Chemical Society. 114(26). 10631–10637. 35 indexed citations
16.
Fischer, Alfred & Prabha N. Ibrahim. (1990). Photolysis of nitro-β,γ alkenes: nitro-2,5-cyclohexadienes. Tetrahedron. 46(8). 2737–2746.
17.
Bushnell, Gordon W., Alfred Fischer, & Prabha N. Ibrahim. (1988). Formation of aryliodine(III) derivatives in the nitration of aryl iodides in acetic anhydride. Journal of the Chemical Society Perkin Transactions 2. 1281–1281. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne G. Graham Breakdown of academic impact, for papers by Jennifer J. Bouska Breakdown of academic impact, for papers by John R. Regan Breakdown of academic impact, for papers by Pier F. Cirillo Breakdown of academic impact, for papers by Kevin Kish Breakdown of academic impact, for papers by Elizabeth A. Lunney Breakdown of academic impact, for papers by Laurie Churchill Breakdown of academic impact, for papers by Hong Ding Breakdown of academic impact, for papers by Steven E. Hall Breakdown of academic impact, for papers by John S. Tokarski
Rankless by CCL
2026